Last Updated : March 26, 2018
Details
Generic Name:
fluocinolone acetonide
Project Status:
Withdrawn
Therapeutic Area:
Diabetic macular edema (DME)
Manufacturer:
Knight Therapeutics Inc.
Call for patient/clinician input open:
Brand Name:
Iluvien
Project Line:
Reimbursement Review
Project Number:
SR0549-000
Call for patient/clinician input closed:
Biosimilar:
No
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
Diabetic macular edema (DME)
Key Milestones2 | |
|---|---|
| Call for patient input posted | November 22, 2017 |
| Patient group input closed | January 18, 2018 |
| Clarification: - No patient input submission received | |
| Submission received | December 21, 2017 |
| Submission accepted for review | January 12, 2018 |
| Review initiated | January 15, 2018 |
| Clarification: - Voluntarily withdrawn by the manufacturer on 2018-Mar-23 | |
Last Updated : March 26, 2018